The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials
Andrew Vernon(The University of Texas at El Paso), Payam Nahid(University of California, San Francisco), Lori E. Dodd(National Institutes of Health), Katherine Fielding(London School of Hygiene & Tropical Medicine), Rada Savic(University of California, San Francisco)
Cited by 109
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
|PubMed|2010|1.1k
Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States
|PsycEXTRA Dataset|2005|694
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548